I'm calling it..., page-54

Thanks for your comments. You raise good points.

I don't deal with options, so I can't comment on this.

However I agree that the company's directors and exec's are paid well, but this doesn't indicate that the company's driving force is money. MSB is not a bank lol. (Side note, you might want to re-negotiate terms with any bosses you currently have if you are turning up to work without monetary incentive )

If MSB were looking for a cash cow, I would expect their research and advertising to push products we don't need in order to stay alive. Examples: Hand creams or anti-balding or ageing agents etc etc. Big pharma does this all the time and do you know why? EZ money.

MSB home page:

"Our lead product candidates under investigation are:

• MPC-150-IM for chronic heart failure
• MPC-06-ID for chronic low back pain due to disc degeneration
• MSC-100-IV for acute graft versus host disease
• MPC-300-IV for biologic refractory rheumatoid arthritis and diabetic nephropathy

We also have a strong emerging pipeline of products for follow-on indications."

Call me naive, but the above are very serious, life degenerating illnesses. MSB is pioneering to work for a solution. A company looking to make a quick buck really just tries to re-invent the wheel.